{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:09:43Z","timestamp":1793232583707,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["1DP2DA053720"],"award-info":[{"award-number":["1DP2DA053720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["1DP2DA053720"],"award-info":[{"award-number":["1DP2DA053720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01266-0","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T06:39:33Z","timestamp":1751870373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida"],"prefix":"10.1186","volume":"22","author":[{"given":"Bel\u00e9n","family":"Hervera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Chueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Scheidell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Ciraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Soto","family":"Sugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Plesons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Serota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R.","family":"Balise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Meaders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"1","key":"1266_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","volume":"76","author":"H Bradley","year":"2022","unstructured":"Bradley H, Hall EW, Asher A, Furukawa NW, Jones CM, Shealey J, et al. Estimated number of people who inject drugs in the United States. Clin Infect Dis. 2022;76(1):96\u2013102. https:\/\/doi.org\/10.1093\/cid\/ciac543.","journal-title":"Clin Infect Dis"},{"key":"1266_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). HIV surveillance report, 2021; vol. 34. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html.\u202fAccessed 5 May 2021."},{"key":"1266_CR3","unstructured":"Centers for Disease Control and Prevention (CDC). HIV and HCV infection and related behaviors among persons who use drugs\u20146 U.S. In: Syringe services programs, 2021\u20132022. HIV surveillance special report 33. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed 14 December 2023."},{"issue":"7","key":"1266_CR4","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","volume":"71","author":"NL McCarthy","year":"2020","unstructured":"McCarthy NL, Baggs J, See I, Reddy SC, Jernigan JA, Gokhale RH, Fiore AE. Bacterial infections associated with substance use disorders, large Cohort of United States hospitals, 2012\u20132017. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(7):e37\u201344. https:\/\/doi.org\/10.1093\/cid\/ciaa008.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"1266_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jrh.12129","volume":"32","author":"T Browne","year":"2016","unstructured":"Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health Off J Am Rural Health Assoc Nat Rural Health Care Assoc. 2016;32(1):92\u2013101. https:\/\/doi.org\/10.1111\/jrh.12129.","journal-title":"J Rural Health Off J Am Rural Health Assoc Nat Rural Health Care Assoc"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, Mimiaga MJ, Saitz R, Bazzi AR. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.037.","journal-title":"Drug Alcohol Depend"},{"key":"1266_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108684","volume":"137","author":"EJ Austin","year":"2022","unstructured":"Austin EJ, Tsui JI, Barry MP, Tung E, Glick SN, Ninburg M, et al. Health care-seeking experiences for people who inject drugs with hepatitis C: qualitative explorations of stigma. J Subst Abuse Treat. 2022;137: 108684. https:\/\/doi.org\/10.1016\/j.jsat.2021.108684.","journal-title":"J Subst Abuse Treat"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"215013192311612","DOI":"10.1177\/21501319231161208","volume":"14","author":"D Bradford","year":"2023","unstructured":"Bradford D, Parman M, Levy S, Turner WH, Li L, Leisch L, Eaton E, Crockett KB. HIV and addiction services for people who inject drugs: healthcare provider perceptions on integrated care in the U.S. South. J Prim Care Commun Health. 2023;14:21501319231161210. https:\/\/doi.org\/10.1177\/21501319231161208.","journal-title":"J Prim Care Commun Health"},{"key":"1266_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-00961-8","author":"C Scaramutti","year":"2024","unstructured":"Scaramutti C, Hervera B, Rivera Y, Chueng TA, Forrest DW, Suarez E, et al. Improving access to HIV care among people who inject drugs through tele-harm reduction: A qualitative analysis of perceived discrimination and stigma. Harm Reduction J. 2024. https:\/\/doi.org\/10.1186\/s12954-024-00961-8.","journal-title":"Harm Reduction J"},{"issue":"2","key":"1266_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1001\/archinte.167.2.166","volume":"167","author":"GL Armstrong","year":"2007","unstructured":"Armstrong GL. Injection drug users in the United States, 1979\u20132002. Arch Intern Med. 2007;167(2):166. https:\/\/doi.org\/10.1001\/archinte.167.2.166.","journal-title":"Arch Intern Med"},{"key":"1266_CR11","unstructured":"National Institute on Drug Abuse (NIDA). Sex and Gender Differences in Substance Use. Retrieved from https:\/\/nida.nih.gov\/publications\/research-reports\/substance-use-in-women\/sex-gender-differences-in-substance-use. 2022, May 4. Accessed on 14 December, 2023."},{"key":"1266_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/289012","volume":"2013","author":"KD Wagner","year":"2013","unstructured":"Wagner KD, Jackson Bloom J, Hathazi SD, Sanders B, Lankenau SE. Control over drug acquisition, preparation, and injection: Implications for HIV and HCV risk among young female injection drug users. ISRN Addict. 2013;2013:1\u20139. https:\/\/doi.org\/10.1155\/2013\/289012.","journal-title":"ISRN Addict"},{"key":"1266_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004988","author":"D Tracy","year":"2014","unstructured":"Tracy D, Hahn JA, Fuller Lewis C, Evans J, Brice\u00f1o A, Morris MD, et al. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO study cohort. BMJ Open. 2014. https:\/\/doi.org\/10.1136\/bmjopen-2014-004988.","journal-title":"BMJ Open"},{"issue":"1","key":"1266_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12954-015-0041-6","volume":"12","author":"E Tuchman","year":"2015","unstructured":"Tuchman E. Women\u2019s injection drug practices in their own words: a qualitative study. Harm Reduct J. 2015;12(1):6. https:\/\/doi.org\/10.1186\/s12954-015-0041-6.","journal-title":"Harm Reduct J"},{"issue":"9","key":"1266_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/10826084.2017.1299182","volume":"52","author":"CN Behrends","year":"2017","unstructured":"Behrends CN, Li C-S, Gibson DR. Decreased odds of injection risk behavior associated with direct versus indirect use of syringe exchange: evidence from two California cities. Subst Use Misuse. 2017;52(9):1145\u201353. https:\/\/doi.org\/10.1080\/10826084.2017.1299182.","journal-title":"Subst Use Misuse"},{"key":"1266_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00689-3","author":"KM Rich","year":"2022","unstructured":"Rich KM, Zubiago J, Murphy M, Guardado R, Wurcel AG. The association of gender with receptive and distributive needle sharing among individuals who inject drugs. Harm Reduct J. 2022. https:\/\/doi.org\/10.1186\/s12954-022-00689-3.","journal-title":"Harm Reduct J"},{"issue":"1\u20132","key":"1266_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2011.12.020","volume":"124","author":"DC Des Jarlais","year":"2012","unstructured":"Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124(1\u20132):95\u2013107. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.12.020.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1266_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/jvh.12628","volume":"24","author":"A Esmaeili","year":"2016","unstructured":"Esmaeili A, Mirzazadeh A, Carter GM, Esmaeili A, Hajarizadeh B, Sacks HS, et al. Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis. J Viral Hepat. 2016;24(2):117\u201327. https:\/\/doi.org\/10.1111\/jvh.12628.","journal-title":"J Viral Hepat"},{"issue":"11","key":"1266_CR19","doi-asserted-by":"publisher","first-page":"e0242165","DOI":"10.1371\/journal.pone.0242165","volume":"15","author":"J Capizzi","year":"2020","unstructured":"Capizzi J, Leahy J, Wheelock H, Garcia J, Strnad L, Sikka M, Menza TW. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLoS ONE. 2020;15(11):e0242165. https:\/\/doi.org\/10.1371\/journal.pone.0242165.","journal-title":"PLoS ONE"},{"issue":"Supplement_5","key":"1266_CR20","doi-asserted-by":"publisher","first-page":"S451","DOI":"10.1093\/infdis\/jiaa012","volume":"222","author":"JR Coyle","year":"2020","unstructured":"Coyle JR, Freeland M, Eckel ST, Hart AL. Trends in morbidity, mortality, and cost of hospitalizations associated with infectious disease sequelae of the opioid epidemic. J Infect Dis. 2020;222(Supplement_5):S451\u20137. https:\/\/doi.org\/10.1093\/infdis\/jiaa012.","journal-title":"J Infect Dis"},{"key":"1266_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa074","author":"EF Eaton","year":"2020","unstructured":"Eaton EF, Westfall AO, McClesky B, Paddock CS, Lane PS, Cropsey KL, et al. In-hospital illicit drug use and patient-directed discharge: Barriers to care for patients with injection-related infections. Open Forum Infect Dis. 2020. https:\/\/doi.org\/10.1093\/ofid\/ofaa074.","journal-title":"Open Forum Infect Dis"},{"key":"1266_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.029.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"1266_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/iwj.13572","volume":"18","author":"BA Cahn","year":"2021","unstructured":"Cahn BA, Bartholomew TS, Patel HP, Pastar I, Tookes HE, Lev-Tov H. Correlates of injection-related wounds and skin infections amongst persons who inject drugs and use a syringe service programme: a single center study. Int Wound J. 2021;18(5):701\u20137. https:\/\/doi.org\/10.1111\/iwj.13572.","journal-title":"Int Wound J"},{"key":"1266_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00378-z","author":"M Shah","year":"2020","unstructured":"Shah M, Wong R, Ball L, Puka K, Tan C, Shojaei E, et al. Risk factors of infective endocarditis in persons who inject drugs. Harm Reduct J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00378-z.","journal-title":"Harm Reduct J"},{"key":"1266_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000001408","author":"LM Nerlander","year":"2017","unstructured":"Nerlander LM, Hess KL, Rose CE, Sionean C, Thorson A, Broz D, et al. Exchange sex and HIV infection among women who inject drugs\u201420 US cities, 2009. JAIDS J Acquir Immune Defic Syndro. 2017. https:\/\/doi.org\/10.1097\/qai.0000000000001408.","journal-title":"JAIDS J Acquir Immune Defic Syndro"},{"key":"1266_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230886","author":"J Valencia","year":"2020","unstructured":"Valencia J, Alvaro-Meca A, Troya J, Guti\u00e9rrez J, Ram\u00f3n C, Rodr\u00edguez A, et al. Gender-based vulnerability in women who inject drugs in a harm reduction setting. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0230886.","journal-title":"PLoS ONE"},{"key":"1266_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105779","volume":"126","author":"KA Brookmeyer","year":"2019","unstructured":"Brookmeyer KA, Haderxhanaj LT, Hogben M, Leichliter J. Sexual risk behaviors and stds among persons who inject drugs: a national study. Prev Med. 2019;126: 105779. https:\/\/doi.org\/10.1016\/j.ypmed.2019.105779.","journal-title":"Prev Med"},{"issue":"4","key":"1266_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.socscimed.2007.11.008","volume":"66","author":"K Shannon","year":"2008","unstructured":"Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911\u201321. https:\/\/doi.org\/10.1016\/j.socscimed.2007.11.008.","journal-title":"Soc Sci Med"},{"key":"1266_CR29","unstructured":"Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance 2018. www.cdc.gov\/std\/stats18\/STDSurveillance2018-full-report.pdf. Accessed 11 December 2023"},{"issue":"6","key":"1266_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/adm.0000000000000795","volume":"15","author":"OK Florsheim","year":"2021","unstructured":"Florsheim OK, Augustine D, Van Ligten MM, de Bocanegra HT, Perry R. Understanding contraceptive needs of women who inject drugs in Orange County: a qualitative study. J Addict Med. 2021;15(6):498\u2013503. https:\/\/doi.org\/10.1097\/adm.0000000000000795.","journal-title":"J Addict Med"},{"issue":"6","key":"1266_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/10826084.2022.2046100","volume":"57","author":"JD Scheidell","year":"2022","unstructured":"Scheidell JD, Ataiants J, Lankenau SE. Miscarriage and abortion among women attending harm reduction services in Philadelphia: Correlations with individual, interpersonal, and structural factors. Subst Use Misuse. 2022;57(6):999\u20131006. https:\/\/doi.org\/10.1080\/10826084.2022.2046100.","journal-title":"Subst Use Misuse"},{"issue":"21","key":"1266_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12954-024-01116-5","volume":"14","author":"JD Scheidell","year":"2024","unstructured":"Scheidell JD, Chueng T, Ciraldo K, Hervera B, Dakoulas S, Mahachi M, et al. Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities. Harm Reduct J. 2024;14(21):198. https:\/\/doi.org\/10.1186\/s12954-024-01116-5.","journal-title":"Harm Reduct J"},{"key":"1266_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000000659","author":"J Iversen","year":"2015","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV, and health-related harms among women who inject drugs. JAIDS J Acquir Immune Defic Syndro. 2015. https:\/\/doi.org\/10.1097\/qai.0000000000000659.","journal-title":"JAIDS J Acquir Immune Defic Syndro"},{"key":"1266_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000000628","author":"N El-Bassel","year":"2015","unstructured":"El-Bassel N, Strathdee SA. Women who use or inject drugs. JAIDS J Acquir Immune Defic Syndro. 2015. https:\/\/doi.org\/10.1097\/qai.0000000000000628.","journal-title":"JAIDS J Acquir Immune Defic Syndro"},{"issue":"31","key":"1266_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/s0968-8080(08)31345-7","volume":"16","author":"S Pinkham","year":"2008","unstructured":"Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. Reprod Health Matters. 2008;16(31):168\u201381. https:\/\/doi.org\/10.1016\/s0968-8080(08)31345-7.","journal-title":"Reprod Health Matters"},{"key":"1266_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000000627","author":"WM Wechsberg","year":"2015","unstructured":"Wechsberg WM, Deren S, Myers B, Kirtadze I, Zule WA, Howard B, et al. Gender-specific HIV prevention interventions for women who use alcohol and other drugs. JAIDS J Acquir Immune Defic Syndro. 2015. https:\/\/doi.org\/10.1097\/qai.0000000000000627.","journal-title":"JAIDS J Acquir Immune Defic Syndro"},{"key":"1266_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00429-5","author":"S Shirley-Beavan","year":"2020","unstructured":"Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduct J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00429-5.","journal-title":"Harm Reduct J"},{"key":"1266_CR38","unstructured":"Aidsvu.\u00a0Local Data: Miami (Miami-Dade County). https:\/\/aidsvu.org\/local-data\/united-states\/south\/florida\/miami. Accessed 11 May 2023"},{"issue":"2","key":"1266_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/ACM.0000000000003557","volume":"96","author":"H Tookes","year":"2021","unstructured":"Tookes H, Bartholomew TS, Onge JES, Ford H. The university of Miami infectious disease elimination act syringe services program: a blueprint for student advocacy, education, and innovation. Academic Med. 2021;96(2):213\u20137. https:\/\/doi.org\/10.1097\/ACM.0000000000003557.","journal-title":"Academic Med"},{"key":"1266_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drugalcdep.2019.04.025","volume":"202","author":"H Levine","year":"2019","unstructured":"Levine H, Bartholomew TS, Rea-Wilson V, Onugha J, Arriola DJ, Cardenas G, et al. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program. Drug Alcohol Depend. 2019;202:13\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.04.025.","journal-title":"Drug Alcohol Depend"},{"key":"1266_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108344","volume":"127","author":"TS Bartholomew","year":"2021","unstructured":"Bartholomew TS, Feaster DJ, Patel H, Forrest DW, Tookes HE. Reduction in injection risk behaviors after implementation of a Syringe Services Program, Miami. Florida J Subst Abuse Treat. 2021;127: 108344. https:\/\/doi.org\/10.1016\/j.jsat.2021.108344.","journal-title":"Florida J Subst Abuse Treat"},{"key":"1266_CR42","unstructured":"Florida Senate Bill 300, Florida Legislature, 2023, SB 300, 2023 Regular Session, Chapter 2023\u201321."},{"issue":"1\/2","key":"1266_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/a:1006109028818","volume":"18","author":"LR Metsch","year":"1999","unstructured":"Metsch LR, McCOY CB, Shultz JM, Page JB, Philippe E, McKAY C. Gender comparisons of injection drug use practices in shooting galleries. Popul Res Policy Rev. 1999;18(1\/2):101\u201317. https:\/\/doi.org\/10.1023\/a:1006109028818.","journal-title":"Popul Res Policy Rev"},{"key":"1266_CR44","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10508-015-0686-y","volume":"46","author":"Y Pan","year":"2017","unstructured":"Pan Y, Metsch LR, Wang W, Wang KS, Duan R, Kyle TL, Feaster DJ. Gender differences in HIV sexual risk behaviors among clients of substance use disorder treatment programs in the US. Arch Sexual Behav. 2017;46:1151\u20138. https:\/\/doi.org\/10.1007\/s10508-015-0686-y.","journal-title":"Arch Sexual Behav"},{"issue":"9","key":"1266_CR45","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1080\/10826084.2022.2083171","volume":"57","author":"TA Chueng","year":"2022","unstructured":"Chueng TA, Tookes HE, McLaughlin M, Arcaro-Vinas AM, Serota DP, Bartholomew TS. Injection and sexual behavior profiles among people who inject drugs in Miami. Florida Subst Use Misuse. 2022;57(9):1374\u201382. https:\/\/doi.org\/10.1080\/10826084.2022.2083171.","journal-title":"Florida Subst Use Misuse"},{"key":"1266_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102875","volume":"84","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, Tookes HE, Serota DP, Behrends CN, Forrest DW, Feaster DJ. Impact of routine opt-out HIV\/HCV screening on testing uptake at a syringe services program: an interrupted time series analysis. Int J Drug Policy. 2020;84: 102875. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102875.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1266_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (redcap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"1266_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00385-0","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, Onugha J, Bullock C, Scaramutti C, Patel H, Forrest DW, et al. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami. FL Harm Reduct J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00385-0.","journal-title":"FL. Harm Reduct J"},{"key":"1266_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102716","volume":"78","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, Tookes HE, Bullock C, Onugha J, Forrest DW, Feaster DJ. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: a latent class analysis. Int J Drug Policy. 2020;78: 102716. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102716.","journal-title":"Int J Drug Policy"},{"key":"1266_CR50","volume-title":"SAS\u00ae OnDemand for academics: user's guide","author":"SAS Institute Inc","year":"2021","unstructured":"SAS Institute Inc. SAS\u00ae OnDemand for academics: user\u2019s guide. Cary, NC: SAS Institute Inc; 2021."},{"issue":"7","key":"1266_CR51","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/656212","volume":"202","author":"E Paintsil","year":"2010","unstructured":"Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implications for transmission among injection drug users. J Infect Dis. 2010;202(7):984\u201390. https:\/\/doi.org\/10.1086\/656212.","journal-title":"J Infect Dis"},{"issue":"3","key":"1266_CR52","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.drugpo.2013.10.011","volume":"25","author":"KR Knight","year":"2014","unstructured":"Knight KR, Lopez AM, Comfort M, Shumway M, Cohen J, Riley ED. Single room occupancy (SRO) hotels as mental health risk environments among impoverished women: The intersection of policy, drug use, trauma, and urban space. Int J Drug Policy. 2014;25(3):556\u201361.","journal-title":"Int J Drug Policy"},{"key":"1266_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cpr.2017.06.002","volume":"56","author":"ER Dworkin","year":"2017","unstructured":"Dworkin ER, Menon SV, Bystrynski J, Allen NE. Sexual assault victimization and psychopathology: a review and meta-analysis. Clin Psychol Rev. 2017;56:65\u201381.","journal-title":"Clin Psychol Rev"},{"key":"1266_CR54","unstructured":"Substance Abuse and Mental Health Services Administration. Addressing the specific needs of women for treatment of substance use disorders. In: U.S. Department of Health and Human Services; 2021."},{"issue":"6","key":"1266_CR55","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10508-020-01684-0","volume":"49","author":"M Felsher","year":"2020","unstructured":"Felsher M, Ziegler E, Smith LR, Sherman SG, Amico KR, Fox R, et al. An exploration of pre-exposure prophylaxis (prep) initiation among women who inject drugs. Arch Sex Behav. 2020;49(6):2205\u201312. https:\/\/doi.org\/10.1007\/s10508-020-01684-0.","journal-title":"Arch Sex Behav"},{"key":"1266_CR56","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000002558","author":"AM Roth","year":"2021","unstructured":"Roth AM, Tran NK, Felsher M, Gadegbeku AB, Piecara B, Fox R, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for Women Who Inject Drugs: Results from the project she demonstration study. JAIDS J Acquir Immune Defic Syndro. 2021. https:\/\/doi.org\/10.1097\/qai.0000000000002558.","journal-title":"JAIDS J Acquir Immune Defic Syndro"},{"key":"1266_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00395-y","author":"L Owens","year":"2020","unstructured":"Owens L, Gilmore K, Terplan M, Prager S, Micks E. Providing reproductive health services for women who inject drugs: a pilot program. Harm Reduct J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00395-y.","journal-title":"Harm Reduct J"},{"issue":"12","key":"1266_CR58","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1080\/10826084.2020.1788088","volume":"55","author":"L Owens","year":"2020","unstructured":"Owens L, Micks E, Moreno C, Glick S. Reproductive health care utilization by women who inject drugs and exchange sex in the Seattle area. Subst Use Misuse. 2020;55(12):2020\u20134. https:\/\/doi.org\/10.1080\/10826084.2020.1788088.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1266_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/09687637.2013.776517","volume":"21","author":"S Fraser","year":"2014","unstructured":"Fraser S, Treloar C, Bryant J, Rhodes T. Hepatitis C prevention education needs to be grounded in social relationships. Drugs Educ Prevent Policy. 2014;21(1):88\u201392. https:\/\/doi.org\/10.3109\/09687637.2013.776517.","journal-title":"Drugs Educ Prevent Policy."},{"key":"1266_CR60","unstructured":"Werner, D., Young, N.K., Dennis, K, Amatetti, S. (2007). Family-centered treatment for women with substance use disorders \u2013 history, key elements and challenges. https:\/\/www.samhsa.gov\/sites\/default\/files\/family_treatment_paper508v.pdf. Accessed 12 April 2023."},{"issue":"1","key":"1266_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540120500101625","volume":"18","author":"SG Sherman","year":"2006","unstructured":"Sherman SG, German D, Cheng Y, Marks M, Bailey-Kloche M. The evaluation of the jewel project: an innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care. 2006;18(1):1\u201311. https:\/\/doi.org\/10.1080\/09540120500101625.","journal-title":"AIDS Care"},{"key":"1266_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/269123","volume":"2012","author":"S Pinkham","year":"2012","unstructured":"Pinkham S, Stoicescu C, Myers B. Developing effective health interventions for women who inject drugs: Key areas and recommendations for program development and policy. Adv Prev Med. 2012;2012:1\u201310. https:\/\/doi.org\/10.1155\/2012\/269123.","journal-title":"Adv Prev Med"},{"key":"1266_CR63","unstructured":"Stern R, Wilmot R, Munroe V. Evaluation report of the sheway project for high-risk and parenting women. british columbia centre of excellence for women\u2019s health; 2000. Available from: https:\/\/cewh.ca\/wp-content\/uploads\/2012\/05\/2000_Evaluation-Report-of-the-Sheway-Project.pdf"},{"key":"1266_CR64","unstructured":"Salmon A. sharing the journey: the sheway model of care. vancouver coastal health; 2013. Available from: https:\/\/www.vch.ca\/sites\/default\/files\/import\/documents\/Sheway-Model-of-Care-Sharing-the-Journey.pdf"},{"issue":"3","key":"1266_CR65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/her\/cyr005","volume":"26","author":"WM Wechsberg","year":"2011","unstructured":"Wechsberg WM, Browne FA, Middlesteadt Ellerson R, Zule WA, Howard BN. Adapting the Women\u2019s CoOp intervention to prevent HIV among women who use substances in the United States and South Africa. Health Educ Res. 2011;26(3):471\u201380. https:\/\/doi.org\/10.1093\/her\/cyr005.","journal-title":"Health Educ Res"},{"key":"1266_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12905-017-0433-8","volume":"17","author":"WM Wechsberg","year":"2017","unstructured":"Wechsberg WM, Ndirangu JW, Speizer IS, Zule WA, Gumula W, Peasant C, Browne FA, Dunlap L. An implementation science protocol of the Women\u2019s Health CoOp in healthcare settings in Cape Town, South Africa: A stepped-wedge design. BMC Womens Health. 2017;17:85. https:\/\/doi.org\/10.1186\/s12905-017-0433-8.","journal-title":"BMC Womens Health"},{"key":"1266_CR67","unstructured":"United Nations Office on Drugs and Crime (UNODC). Addressing the specific needs of women who inject drugs: Practical guide for service providers on gender-responsive HIV services. United Nations; 2016. Available from: https:\/\/www.unodc.org\/documents\/hiv-aids\/2016\/Addressing_the_specific_needs_of_women_who_inject_drugs_Practical_guide_for_service_providers_on_gender-responsive_HIV_services.pdf"},{"key":"1266_CR68","unstructured":"United Nations Office on Drugs and Crime. Final CND side event report: 64th session of the commission on narcotic drugs, 12\u201316 April 2021. In: Secretariat to the governing bodies; 2021. Available from: https:\/\/www.unodc.org\/documents\/commissions\/CND\/CND_Sessions\/CND_64\/Final_CND_Side_Event_Report_2021_rev2.pdf"},{"key":"1266_CR69","unstructured":"United Nations. Substance abuse treatment and care for women: Case studies and lessons learned, 2004. Vienna: United Nations Office on Drugs and Crime. https:\/\/www.unodc.org\/documents\/drug-prevention-and-treatment\/UNODC_Women_Treatment_Case_Studies_E.pdf. Accessed 21 April 2024."},{"issue":"22","key":"1266_CR70","doi-asserted-by":"publisher","first-page":"12073","DOI":"10.3390\/ijerph182212073","volume":"18","author":"F Mercer","year":"2021","unstructured":"Mercer F, Miler JA, Pauly B, Carver H, Hn\u00edzdilov\u00e1 K, Foster R, Parkes T. Peer Support and Overdose Prevention Responses: A Systematic \u2018State-of-the-Art\u2019 Review. Int J Environ Res Public Health. 2021;18(22):12073.","journal-title":"Int J Environ Res Public Health"},{"key":"1266_CR71","unstructured":"The White House. Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. 2025. https:\/\/www.whitehouse.gov\/presidential-actions\/2025\/01\/defending-women-from-gender-ideology-extremism-and-restoring-biological-truth-to-the-federal-government\/ Accessed 10 June 2025."},{"key":"1266_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0280-z","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Kravietz A, Bartholomew TS, Forrest D, Tookes HE. Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami idea syringe exchange. Harm Reduct J. 2019. https:\/\/doi.org\/10.1186\/s12954-019-0280-z.","journal-title":"Harm Reduct J"}],"updated-by":[{"DOI":"10.1186\/s12954-025-01348-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000}}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01266-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01266-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01266-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:04:09Z","timestamp":1766156649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01266-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01266-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The author name \u201cNobuyo Nakamuro\u201d was incorrectly written and corrected in the article PDF.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12954-025-01348-z","URL":"https:\/\/doi.org\/10.1186\/s12954-025-01348-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All authors of the present manuscript declare that they have no conflict of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee(s) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was not obtained from participants included in the study because it was deemed exempt by the University of Miami IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approvals and consent to participate"}}],"article-number":"117"}}